Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, address the impact of effective treatments of chronic cough on patient quality of life (QOL).
Patients can get embarrassed or rethink venturing out, whether that be to church, the theater, or to dinner, so effective treatments for chronic cough can have a positive impact on their work and home lives, noted Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic.
Transcript
What impact might an effective treatment that resolves the symptoms of chronic cough have on quality of life?
When patients come to our office with a chief complaint of chronic cough, these are the patients who think twice before going to church or going to a theater or going out for dinner. And I think, unfortunately, this has been even more so now in the age of COVID. A lot of times, they are embarrassed, or they just don’t want to be getting dirty looks by coughing—again, especially now. So it can really make a difference.
I do also see a lot of patients whose work requires a lot of talking to customers or employees and it’s really hard for them to be able to maintain a conversation or do a presentation without coughing. So, it could certainly impact not only the quality of life in general, but also their work. And, as I said, sometimes they’re coughing at night and not sleeping well, so it can play a role in many aspects of their daily lives. And I think it’s a huge thing for them.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Understanding Primary and Secondary Nonadherence to Chronic Oral Medication
March 28th 2025Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new research conducted among patients and health care providers and presented by the American Medical Group Association at its 2025 annual meeting, held March 26-29 in Grapevine, Texas.
Read More
Dermatologists Advocating for Inclusive Hair Loss Research and Treatment in the African Diaspora
March 26th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, advocates for increased funding and education to address hair loss disparities within the African diaspora, emphasizing the need for culturally sensitive treatment and research.
Read More